Hyperkalemia

The American Society of Nephrology released new clinical guidance in the Journal of the American Society of Nephrology on the outpatient management of AKI requiring dialysis.

CHICAGO — A potassium binder helped patients with HF who have or are at high risk for hyperkalemia stay on spironolactone at an optimal dose, but showed a signal of HF hospitalization risk, researchers reported.

CHICAGO — In patients with acute MI who underwent PCI, spironolactone did not improve the primary composite outcomes but was linked to reduced risk for new or worsening HF, according to new data from the CLEAR SYNERGY (OASIS-9) trial.

Adults with type 2 diabetes using a GLP-1 receptor agonist are less likely to develop hyperkalemia than those using a DPP-IV inhibitor, according to a study published in JAMA Internal Medicine.

There may be a link between dietary fiber intake and hyperkalemia in patients on maintenance hemodialysis, according to a published cross-sectional study.

Hyperkalemia may be considered a common occurrence in patients with chronic kidney disease, particularly in those with heart failure or diabetes, published data show.

Eating a variety of natural fiber-rich foods and avoiding fiber with phosphate additives may help youth with chronic kidney disease to meet adequate dietary fiber intake.

Long-term patiromer use may be associated with a lower risk of all-cause mortality in adults with chronic kidney disease and hyperkalemia, according to results of published study.

An experimental drug that inhibits aldosterone production reduced albuminuria in patients with chronic kidney disease, according to phase 2 study results published in The Lancet.

A speaker reported that improved differentiation of resistant vs. refractory hypertension is essential in choosing optimal antihypertensive treatment, as the two represent different disease states of elevated blood pressure.